{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:44:58Z","timestamp":1791254698329,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Background\/Objectives: Individuals diagnosed with schizophrenia are susceptible to constipation induced by antipsychotic medications. However, research investigating the prevalence of this adverse effect and its underlying mechanisms is limited. Methods: To address this knowledge gap, a narrative review was conducted on the subject of constipation in patients with schizophrenia. A comprehensive electronic search was conducted in the PubMed and J-Stage databases. Results: The prevalence of constipation in individuals with schizophrenia is high, ranging from 30% to 60%. The risk of constipation increases with high doses of antipsychotics and with the concomitant use of anticholinergics and mood stabilizers. The prevalence of constipation varies by sex, with women demonstrating a higher risk compared to men. Conclusions: Constipation is a prevalent complaint among individuals with schizophrenia, with women exhibiting a higher risk. The underlying pathophysiology of sex differences in constipation is attributed to variations in monoamines within the descending pain inhibitory pathway, which governs the neural circuitry associated with defecation. Constipation can lead to significant complications, underscoring the need for a multifaceted approach to treatment that considers the intestinal environment beyond the mere use of laxatives.<\/jats:p>","DOI":"10.3390\/clinpract15020033","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T11:01:08Z","timestamp":1739271668000},"page":"33","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Challenges of Constipation in People Suffering from Schizophrenia: A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0690-6271","authenticated-orcid":false,"given":"Takahiko","family":"Nagamine","sequence":"first","affiliation":[{"name":"Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Hofu 7470066, Japan"},{"name":"Department of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Bunkyou 1138510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sampogna, G., Di Vincenzo, M., Giuliani, L., Menculini, G., Mancuso, E., Arsenio, E., Cipolla, S., Della Rocca, B., Martiadis, V., and Signorelli, M.S. (2023). A Systematic Review on the Effectiveness of Antipsychotic Drugs on the Quality of Life of Patients with Schizophrenia. Brain Sci., 13.","DOI":"10.3390\/brainsci13111577"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/schbul\/sbq137","article-title":"Risk factors for ileus in patients with schizophrenia","volume":"38","author":"Nielsen","year":"2012","journal-title":"Schizophr. Bull."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eurpsy.2010.03.003","article-title":"Second-generation antipsychotics and constipation: A review of the literature","volume":"26","author":"Hudyana","year":"2011","journal-title":"Eur. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/wps.20204","article-title":"Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"De Hert, M., Dockx, L., Bernagie, C., Peuskens, B., Sweers, K., Leucht, S., Tack, J., Van de Straete, S., Wampers, M., and Peuskens, J. (2011). Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: A retrospective descriptive study. BMC Gastroenterol., 11.","DOI":"10.1186\/1471-230X-11-17"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/psyg.12875","article-title":"The relation between second-generation antipsychotics and laxative use in elderly patients with schizophrenia","volume":"22","author":"Lin","year":"2022","journal-title":"Psychogeriatrics"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Chiang, C.Y., Lo, S.C., Beckstead, J.W., and Yang, C.Y. (2024). Associations between constipation risk and lifestyle, medication use, and affective symptoms in patients with schizophrenia: A multicenter cross-sectional study. Soc. Psychiatry Psychiatr. Epidemiol., Epub ahead of print.","DOI":"10.1007\/s00127-024-02743-w"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.euroneuro.2020.12.008","article-title":"Factors associated with laxative use in schizophrenia patients treated with second-generation antipsychotics","volume":"43","author":"Lin","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"112506","DOI":"10.1016\/j.psychres.2019.112506","article-title":"A systematic review of sex-based differences in effectiveness and adverse effects of clozapine","volume":"280","author":"Alberich","year":"2019","journal-title":"Psychiatry Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40263-024-01089-w","article-title":"Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia","volume":"38","author":"Galbally","year":"2024","journal-title":"CNS Drugs"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/10398562211042368","article-title":"Predictors of laxative use in inpatients with schizophrenia on clozapine","volume":"30","author":"Sazhin","year":"2022","journal-title":"Australas. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/YIC.0000000000000354","article-title":"Prevalence and predictors of laxatives use in clozapine-related constipation: An observational study","volume":"36","author":"Nakamura","year":"2021","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/08039488.2018.1517189","article-title":"Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland","volume":"72","author":"Ingimarsson","year":"2018","journal-title":"Nord. J. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2174\/1570159X15666170630163616","article-title":"Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects","volume":"16","author":"Siafis","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/cphy.c130055","article-title":"Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions","volume":"4","author":"Browning","year":"2014","journal-title":"Compr. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"G195","DOI":"10.1152\/ajpgi.00181.2023","article-title":"Alterations in descending brain-spinal pathways regulating colorectal motility in a rat model of Parkinson\u2019s disease","volume":"326","author":"Sawamura","year":"2024","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1113\/JP279942","article-title":"Sexually dimorphic response of colorectal motility to noxious stimuli in the colorectum in rats","volume":"599","author":"Horii","year":"2021","journal-title":"J. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jviscsurg.2015.02.004","article-title":"Ogilvie\u2019s syndrome-acute colonic pseudo-obstruction","volume":"152","author":"Pereira","year":"2015","journal-title":"J. Visc. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.47391\/JPMA.8661","article-title":"Ogilvie Syndrome Secondary Due To Underlying Hypokalaemia And Anticholinergics: Case Report And Brief Review Of The Literature","volume":"73","author":"Iftikhar","year":"2023","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_20","first-page":"53","article-title":"Clozapine related Ogilvie syndrome with fatal outcome","volume":"55","author":"Demir","year":"2020","journal-title":"Riv. Psichiatr."},{"key":"ref_21","first-page":"e53377","article-title":"Clozapine-Induced Refractory Colonic Pseudo-Obstruction","volume":"16","author":"Siriwardena","year":"2024","journal-title":"Cureus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4088\/JCP.v69n0509","article-title":"Life-threatening clozapine-induced gastrointestinal hypomotility: An analysis of 102 cases","volume":"69","author":"Palmer","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"ref_23","first-page":"e51389","article-title":"Mortality Due to Complications Associated With Acute Ogilvie\u2019s Syndrome in an Older Adult Treated for Psychosis: A Case Report","volume":"15","author":"Ali","year":"2023","journal-title":"Cureus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/JCP.0000000000001587","article-title":"Lethal Acute Colonic Pseudo-Obstruction in a Patient Using a Combination of Olanzapine and Clozapine","volume":"42","author":"Bouhuis","year":"2022","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s40263-021-00859-0","article-title":"Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and Treatment","volume":"35","author":"Xu","year":"2021","journal-title":"CNS Drugs"},{"key":"ref_26","first-page":"CD011128","article-title":"Pharmacological treatment for antipsychotic-related constipation","volume":"1","author":"Clarke","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ihara, E., Manabe, N., Ohkubo, H., Ogasawara, N., Ogino, H., Kakimoto, K., Kanazawa, M., Kawahara, H., Kusano, C., and Kuribayashi, S. (2024). Evidence-Based Clinical Guidelines for Chronic Constipation 2023. Digestion, 1\u201328. Epub ahead of print.","DOI":"10.1159\/000540912"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12938\/bmfh.2023-040","article-title":"Effect of magnesium oxide with probiotics on bowel movements in elderly orthopedic patients with chronic constipation: A retrospective chart review","volume":"43","author":"Nagamine","year":"2024","journal-title":"Biosci. Microbiota Food Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.12938\/bmfh.2020-022","article-title":"The effect of probiotics on bowel movement and metabolic parameters in schizophrenia patients: A retrospective chart review","volume":"39","author":"Nagamine","year":"2020","journal-title":"Biosci. Microbiota Food Health"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16518","DOI":"10.3748\/wjg.v20.i44.16518","article-title":"Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications","volume":"20","author":"LeBlanc","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/npr2.12227","article-title":"Gut permeability and its clinical relevance in schizophrenia","volume":"42","author":"Ishida","year":"2022","journal-title":"Neuropsychopharmacol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Namihira, M., Inoue, N., Watanabe, Y., Hayashi, T., Murotomi, K., Hirayama, K., and Sato, N. (2024). Combination of 3 probiotics restores attenuated adult neurogenesis in germ-free mice. Stem Cells, sxae077.","DOI":"10.1093\/stmcls\/sxae077"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.encep.2023.11.006","article-title":"Constipation in hospitalized psychiatric patients: An underestimated common phenomenon. Retrospective epidemiological study in an adult psychiatric hospital setting","volume":"50","author":"Bornes","year":"2024","journal-title":"Encephale"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CEG.S485504","article-title":"Associations of Schizophrenia and Major Depressive Disorder with Constipation: A Mendelian Randomization Study","volume":"17","author":"Liu","year":"2024","journal-title":"Clin. Exp. Gastroenterol."}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/15\/2\/33\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:31:35Z","timestamp":1760027495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/15\/2\/33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["clinpract15020033"],"URL":"https:\/\/doi.org\/10.3390\/clinpract15020033","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]}}}